SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-058655
Filing Date
2023-07-21
Accepted
2023-07-21 08:00:18
Documents
14
Period of Report
2023-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182127-8k_tradeup.htm   iXBRL 8-K 39773
2 PROMISSORY NOTE, DATED JULY 20, 2023, ISSUED BY TRADEUP ACQUISITION CORP. TO TRA ea182127ex10-1_tradeup.htm EX-10.1 32207
  Complete submission text file 0001213900-23-058655.txt   310682

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE uptd-20230720.xsd EX-101.SCH 4178
4 XBRL DEFINITION FILE uptd-20230720_def.xml EX-101.DEF 27273
5 XBRL LABEL FILE uptd-20230720_lab.xml EX-101.LAB 37772
6 XBRL PRESENTATION FILE uptd-20230720_pre.xml EX-101.PRE 25893
8 EXTRACTED XBRL INSTANCE DOCUMENT ea182127-8k_tradeup_htm.xml XML 6778
Mailing Address 437 MADISON AVENUE, 27TH FLOOR NEW YORK NY 10022
Business Address 437 MADISON AVENUE, 27TH FLOOR NEW YORK NY 10022 (732) 910-9692
TradeUP Acquisition Corp. (Filer) CIK: 0001844417 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40608 | Film No.: 231101120
SIC: 2836 Biological Products, (No Diagnostic Substances)